iSeed Ventures is an early-stage investor with a simple motto: "Investing in dreams. Supporting visions. Navigating growth." For founders researching iSeed Ventures funding, the pitch is straightforward — seed and Series A capital in the $200,000 to $2 million range for high-potential startups, with a track record that includes exits to Roche, PRA/ICON and Nvidia.

Investment thesis

iSeed Ventures positions itself as a foundational ally for founders: "When you win, we win." The firm invests early and stays through each phase of growth, providing "tools and guidance to successfully navigate each phase". Its focus areas centre on AI, IoT and healthcare, with third-party directories also tracking SaaS & software and fintech in its portfolio. It typically leads and co-leads rounds rather than following.

Sectors and stages

The firm invests at seed and Series A (with pre-seed activity tracked in its profile), in SaaS & software, fintech, healthcare and AI. Geographies span the United States and India (with Austria also appearing in its deal footprint). It is frequently listed among India's popular micro VCs alongside names like 100X.VC and Fluid Ventures — a good signal for founders seeking an institutional-quality seed investor at smaller cheque sizes.

Fund size and cheque size

The fund's total corpus is not publicly disclosed. What is public: investments range from $200,000 up to $2 million, at seed and Series A stages. That places iSeed squarely in the micro-VC bracket — meaningful seed capital without the pressure of a large fund's deployment targets.

Notable portfolio

iSeed Ventures' portfolio page is built around founder testimonials from genuine exits. Frank Westermann, Founder and CEO of mySugr, says iSeed was an early-stage investor in his first company and that partner Adam Lin's board advice was "an indispensable part of our journey resulting in the successful exit to Roche Pharmaceutical". Randy Swanson, CEO of Care Innovations, credits iSeed as "a crucial step on our path to growth and a successful acquisition" by PRA (now ICON plc), with Adam Lin as lead board member. And James Wu, Founder and CEO of DeepMap, calls iSeed "our first investor", a crucial partner "throughout the different phases" — DeepMap was acquired by Nvidia.

Partners

The firm's General Partner is Adam Lin, who sits on portfolio boards and is repeatedly singled out by founders for hands-on, high-quality engagement and network access. The site frames the whole team as committed to founders' success: "Meet the team providing unwavering support to the companies they back."

Programs, credits and perks

iSeed Ventures does not advertise a formal accelerator, cloud-credit programme or perks platform. The support model is partner-led — board-level guidance, network connections and hands-on help from the first cheque to exit.

How to apply for funding

iSeed Ventures runs a "Get in touch" form on iseedvc.com — founders submit their name, email, company, industry and message, and can upload a document (your pitch deck). The firm says it will be in touch to discuss the opportunity for partnership. Given Adam Lin's board-centric style, founders should pitch with a deck that shows why they want an engaged, long-term lead — not a passive cheque. Warm introductions through the Indian micro-VC network also work, given the firm's visibility in the ecosystem.

Why it matters for founders

iSeed Ventures offers what many seed founders actually want: a lead investor who shows up on the board and stays to the exit. With $200K–$2M cheques and exits to Roche, PRA and Nvidia on the record, it punches above its micro-VC weight — especially for SaaS, fintech and health-tech founders.